GlassScriptPhysician profile
Michael Aaron Polisky
NPI 1730289463
$10,809.13
in general payments reported to CMS, 2019-2025
53 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,171 · 2020: $1,908 · 2021: $2,451 · 2022: $2,929 · 2023: $798 · 2024: $315 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,833.05 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Mannkind Corporation | $1,158.77 | 2019-2023 | Afrezza |
| Dexcom, INC. | $1,101.38 | 2019-2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $743.67 | 2019-2023 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $726.56 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $584.55 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $567.90 | 2019-2025 | |
| Tandem Diabetes Care, INC. | $337.94 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $305.50 | 2019-2023 | Omnipod |
| Abbott Laboratories | $291.67 | 2019-2025 | Freestyle Libre 3 |
| Corcept Therapeutics | $289.21 | 2019-2022 | |
| Radius Health, INC. | $283.14 | 2019-2023 | Tymlos |
| Merck Sharp & Dohme LLC | $219.49 | 2019-2021 | |
| Lifescan, INC. | $215.09 | 2020-2023 | |
| Zealand Pharma US, INC. | $203.43 | 2020-2022 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Polisky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.